(Q42210922)

English

Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3β, down-regulated NF-κB expression, and ameliorated BBB permeability

scientific article published on 12 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 October 2017

Pretreatment by evodiamine is neuroprotective in cerebral ischemia: up-regulated pAkt, pGSK3β, down-regulated NF-κB expression, and ameliorated BBB permeability (English)

1 reference

Europe PubMed Central

18 October 2017

0 references

cerebral infarction

1 reference

based on heuristic

inferred from title

author name string

Ting Zhao

1

1 reference

Europe PubMed Central

18 October 2017

Xiangjian Zhang

2

1 reference

Europe PubMed Central

18 October 2017

Yuan Zhao

3

1 reference

Europe PubMed Central

18 October 2017

Lan Zhang

4

1 reference

Europe PubMed Central

18 October 2017

Xue Bai

5

1 reference

Europe PubMed Central

18 October 2017

Jian Zhang

6

1 reference

Europe PubMed Central

18 October 2017

Xumeng Zhao

7

1 reference

Europe PubMed Central

18 October 2017

Linyu Chen

8

1 reference

Europe PubMed Central

18 October 2017

Lina Wang

9

1 reference

Europe PubMed Central

18 October 2017

Lili Cui

10

1 reference

Europe PubMed Central

18 October 2017

publication date

12 June 2014

1 reference

Europe PubMed Central

18 October 2017

Neurochemical Research

1 reference

Europe PubMed Central

18 October 2017

39

1 reference

Europe PubMed Central

18 October 2017

1612-1620

1 reference

Europe PubMed Central

18 October 2017

8

1 reference

Europe PubMed Central

18 October 2017

https://scigraph.springernature.com/pub.10.1007/s11064-014-1356-5

0 references

Alzheimer's mechanisms in ischemic brain degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Beneficial effects of sulindac in focal cerebral ischemia: a positive role in Wnt/β-catenin pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The intrinsic PEDF is regulated by PPARγ in permanent focal cerebral ischemia of rat.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Involvement of the Akt/PKB signaling pathway with disease processes

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Polydatin modulates inflammation by decreasing NF-κB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood-brain barrier permeability for its neuroprotective effect in pMCAO rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Post-ischemic inflammation: molecular mechanisms and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The protection by octreotide against experimental ischemic stroke: up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-κB expression.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

In utero gene therapy: the case for.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Evodiamine improves congnitive abilities in SAMP8 and APP(swe)/PS1(ΔE9) transgenic mouse models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The effect of Evodia rutaecarpa extract on cytokine secretion by human mononuclear cells in vitro.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Protective effects of evodiamine on myocardial ischemia-reperfusion injury in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Neuroprotective effect of early and short-time applying sophoridine in pMCAO rat brain: down-regulated TRAF6 and up-regulated p-ERK1/2 expression, ameliorated brain infaction and edema.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1α and Bcl-2, down-regulated Bax, NF-κB expression.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Antioxidant nutrients and hypoxia/ischemia brain injury in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Intragastric administration of evodiamine suppresses NPY and AgRP gene expression in the hypothalamus and decreases food intake in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The activation of Akt/PKB signaling pathway and cell survival.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

The renaissance of GSK3

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Nuclear factor-kappaB contributes to infarction after permanent focal ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Cerebral vascular volume after repeated ischemic insults in the gerbil: comparison with changes in CBF and brain edema

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-kappaB p65/p50 expression

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Tracing the endocytosis of claudin-5 in brain endothelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1356-5

21 January 2018

Role of nuclear factor kappaB in the central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kappaB is activated and promotes cell death in focal cerebral ischemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular and cellular permeability control at the blood-brain barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24919817

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11064-014-1356-5

1 reference

Europe PubMed Central

18 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210922&oldid=1936009127"